BioTelemetry Inc (BEAT)

32.00
NASDAQ : Health Care
Prev Close 31.65
Day Low/High 31.50 / 32.50
52 Wk Low/High 15.25 / 39.20
Avg Volume 497.90K
Exchange NASDAQ
Shares Outstanding 32.36M
Market Cap 1.02B
EPS 1.90
P/E Ratio 20.82
Div & Yield N.A. (N.A)

Latest News

Saber-Rattling Sparks Selling

VIX climbs while gold and bonds catch a bid.

BEAT Crosses Above Average Analyst Target

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $33.00, changing hands for $34.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BioTelemetry, Inc. Completes LifeWatch AG Acquisition

BioTelemetry, Inc. Completes LifeWatch AG Acquisition

Deal Solidifies BioTelemetry's Leadership Position in Remote Cardiac Monitoring

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $28.67, changing hands for $29.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $28.67, changing hands for $28.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Noteworthy Thursday Option Activity: BEAT, OCN, CTL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in BioTelemetry Inc , where a total volume of 2,390 contracts has been traded thus far today, a contract volume which is representative of approximately 239,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 45.3% of BEAT's average daily trading volume over the past month, of 528,120 shares.

BioTelemetry, Inc. Reports First Quarter 2017 Financial Results

Company Reports Record Quarterly Revenue and Patient Volume

BioTelemetry, Inc. Issues Prospectus For Public Tender Offer To Acquire LifeWatch AG

LifeWatch Board of Directors Supports BioTelemetry Tender Offer

Commit To Buy BioTelemetry At $27, Earn 13% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc shares, but cautious about paying the going market price of $30.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $27 strike, which has a bid at the time of this writing of $2.10.

BioTelemetry, Inc. Launches A Tender Offer To Acquire LifeWatch AG

Strengthens Remote Patient Monitoring Platform

The BEAT Goes on at BioTelemetry

The BEAT Goes on at BioTelemetry

BEAT is the ticker symbol for this health care name, which we think Sonny and Cher would love.

BioTelemetry, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results

Company Reports Record Results

BioTelemetry Reaches Analyst Target Price

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $25.00, changing hands for $25.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Sprint & BioTelemetry, Inc. Receive A 2017 IoT Evolution Business Impact Award

Award Recognizes Businesses that Deployed Successful IoT Solutions

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

Extends reach into rapidly expanding digital population health management market

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $16.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $15 strike, which has a bid at the time of this writing of $1.30.

TheStreet Quant Rating: B (Buy)